Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

2 days ago 1

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Maham Fatima

Thu, September 3, 2026 at 7:19 AM EDT 4 min read

On August 3, Ethos Technologies (NASDAQ:LIFE) reported second-quarter results for the period ended June 30, showing revenue climbing 113% year over year to $189.6 million, the company's second straight quarter above triple-digit growth. Alongside the print, Ethos said its board had authorized a new $100 million buyback of its Class A common stock. For a life insurance technology company that only recently went public, doubling revenue while also committing fresh capital to share repurchases is the kind of combination that invites a closer look at what is actually driving the numbers underneath.

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Growth That Keeps Compounding

The top line breaks down into two channels moving at different speeds. Direct channel revenue grew 131% year over year to $116.5 million, which Ethos said came with similar unit economics to prior periods, while third-party revenue grew 90% to $73.1 million. Behind those dollars sits actual policy volume. Ethos activated 107,847 new policies in the quarter, up 133% year over year, extending past 100,000 added families in a single three-month stretch. Gross profit came in at $185.5 million, a 98% gross margin, showing that the underlying cost of writing each policy remains small relative to what it generates in revenue.

Cash generation kept pace too. The company produced $35.7 million in net cash from operations during the quarter and $66.9 million over the first six months of 2026, helping push its cash and cash equivalents balance to $112.2 million from $91.1 million at the end of 2025. Ethos also widened its product shelf, launching a Juvenile IUL policy in partnership with North American. Management's outlook points to more of the same: third-quarter revenue guidance of $160 million to $164 million implies 73% year-over-year growth at the midpoint, and full-year 2026 guidance calls for revenue between $727 million and $731 million, an 88% increase, alongside adjusted EBITDA of $119 million to $123 million for the year.

Growth Comes At A Cost

The strain shows up once the growth is measured against what actually reaches the bottom line. GAAP net income was $19.5 million, a 10% margin, barely above the $18.5 million Ethos earned in the same quarter a year ago despite revenue more than doubling in between. Contribution margin, which strips out sales and marketing costs, fell to 33% from 42% a year earlier. Adjusted EBITDA margin slipped to 19% from 23%, even though the EBITDA dollar figure itself grew to $35.2 million from $20.8 million. Revenue per activated policy fell 8% year over year to $1,758, which Ethos attributed to a shift in channel and product mix, meaning each new policy is worth less on average than it used to be.

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway